Palisade Bio, Inc. (PALI) — DEFA14A Filings
All DEFA14A filings from Palisade Bio, Inc.. Browse 2 DEFA14A reports with AI-powered summaries and risk analysis.
DEFA14A Filings (2)
- DEFA14A Filing — Nov 3, 2025
-
Palisade Bio Files Proxy Statement
— Oct 7, 2025 Risk: low
Palisade Bio, Inc. (formerly Seneca Biopharma, Inc.) filed a Definitive Additional Materials proxy statement on October 7, 2025. The company, located in Carlsba
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX